Hologic to Buy Cynosure for $66.00/Shr in Cash
Source: BFW (Bloomberg First Word)
Tickers
CYNO US (Cynosure Inc)
HOLX US (Hologic Inc)
To de-activate this alert, click here
UUID: 7947283
(Bloomberg) -- Hologic agrees to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an equity value of ~$1.65b and an enterprise value of $1.44b net of cash.
Alert: HALISTER- HOLX sees deal adding to adj. EPS immediately
- CYNO halted
- NOTE: Yday, CYNO fell 6.5% after Allergan agreed to buy Zeltiq
- Statement:Link
Source: BFW (Bloomberg First Word)
Tickers
CYNO US (Cynosure Inc)
HOLX US (Hologic Inc)
To de-activate this alert, click here
UUID: 7947283